Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites.

Statnick MA, Schober DA, Gackenheimer S, Johnson D, Beavers L, Mayne NG, Burnett JP, Gadski R, Gehlert DR.

Brain Res. 1998 Nov 9;810(1-2):16-26.

PMID:
9813224
2.

Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines.

Kingston AE, Lowndes J, Evans N, Clark B, Tomlinson R, Burnett JP, Mayne NG, Cockerham SL, Lodge D.

Neuropharmacology. 1998;37(3):277-87.

PMID:
9681926
3.

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, Schoepp DD.

Neuropharmacology. 1998;37(1):1-12.

PMID:
9680254
4.

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S, Cockerman SL, Burnett JP, Belegaje R, Bleakman D, Monn JA.

Neuropharmacology. 1997 Jan;36(1):1-11.

PMID:
9144636
5.

Analysis of NPY receptor subtypes in the human frontal cortex reveals abundant Y1 mRNA and binding sites.

Statnick MA, Schober DA, Mayne NG, Burnett JP, Gehlert DR.

Peptides. 1997;18(1):137-43.

PMID:
9114463
7.

(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)- pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase.

Wermuth CG, Mann A, Schoenfelder A, Wright RA, Johnson BG, Burnett JP, Mayne NG, Schoepp DD.

J Med Chem. 1996 Feb 16;39(4):814-6. No abstract available.

PMID:
8632404
9.
10.

Pharmacological analysis of 4-carboxyphenylglycine derivatives: comparison of effects on mGluR1 alpha and mGluR5a subtypes.

Kingston AE, Burnett JP, Mayne NG, Lodge D.

Neuropharmacology. 1995 Aug;34(8):887-94.

PMID:
8532170
11.

Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylate.

Schoepp DD, Johnson BG, Salhoff CR, Valli MJ, Desai MA, Burnett JP, Mayne NG, Monn JA.

Neuropharmacology. 1995 Aug;34(8):843-50.

PMID:
8532165
12.
13.

Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.

Sharp RL, May PC, Mayne NG, Snyder YM, Burnett JP.

Eur J Pharmacol. 1994 Jan 1;266(1):R1-2.

PMID:
7511109
14.

Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.

Heath WF, Cantrell AS, Mayne NG, Jaskunas SR.

Biochemistry. 1991 Jun 4;30(22):5608-15.

PMID:
2036431
15.

Role of mRNA translational efficiency in bovine growth hormone expression in Escherichia coli.

Schoner BE, Hsiung HM, Belagaje RM, Mayne NG, Schoner RG.

Proc Natl Acad Sci U S A. 1984 Sep;81(17):5403-7.

Supplemental Content

Loading ...
Support Center